Obermatt

Oaktree Acquisition III Life Sciences

NMQ:OACC · KYG6717R1048
Capital MarketsX-Small

360° View

no current rank
Price/Sales
Price/Earnings83
Price/Book
Dividend Yield
Revenue Growth
Profit Growth
Capital Growth51
TSR 52w20
Leverage92
Liquidity
Refinancing77
Combined
Analyst Opinions
Pro Holdings77
Opinion Changes
Market Pulse4

Profile

CountryUSA
IndustryCapital Markets
SizeX-Small
TypePublic Company
ExchangeNASDAQGM
Founded2024
ISINKYG6717R1048
Last UpdateApr 2, 2026

Description

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharm…

Similar Stocks

The companies this stock is ranked against.

Compare Oaktree Acquisition III Life Sciences with its peers
Perceptive Capital Solutions
NMQ:PCSC
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
IB Acquisition
NMQ:IBAC
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Yorkville Acquisition
NMQ:MCGA
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Willow Lane Acquisition
NMQ:WLAC
CountryUSA
IndustryCapital Markets
SizeSmall
Full Stock Analysis →
Wen Acquisition
NMQ:WENN
CountryUSA
IndustryCapital Markets
SizeX-Small
Full Stock Analysis →
Voyager Acquisition
NMQ:VACH
CountryUSA
IndustryCapital Markets
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →